A ngiotensin II has been implicated in the pathobiology of atherosclerosis and in the arterial response to injury and restenosis via mechanisms that include vascular hypertrophy, extracellular matrix production, and cytokine induction. Although the angiotensin-converting enzyme (ACE) is only one of several enzymes that can generate angiotensin II, 1 the enzyme has been allocated a central role in cardiovascular disease development, mainly on the basis of the positive effects observed in response to ACE inhibitor therapy and experimental work involving protein downregulation.2 Certainly, ACE levels seem to correlate with disease development, and ACE protein has been detected in atherosclerotic human coronary 3,4 and carotid lesions.
5Relatively little is known about the signals that regulate ACE expression in vascular cells, but the exposure of vascular smooth muscle cells to fluid shear stress 6 or pulsatile pressure 7 is reported to increase expression of the enzyme. Although an identical phenomenon was initially reported in endothelial cells, 6 several other studies reported exactly the opposite, that is, that arterial levels of shear stress attenuate ACE promoter activity and decrease the expression of ACE mRNA in endothelial cells. [8][9][10] How can fluid shear stress regulate ACE expression? The first hypothesis was that the effects could be attributed to increased transcription as the genes for human, rat, and rabbit ACE all contain a number of shear stress-responsive elements in their promoter regions. These were however found to be inactive, and responsiveness to flow was then attributed to a combination of Barbie and GAGA response elements.